Biofluid 1H NMR-based metabonomic techniques in nutrition research - metabolic effects of dietary isoflavones in humans.

[1]  Elaine Holmes,et al.  The challenges of modeling mammalian biocomplexity , 2004, Nature Biotechnology.

[2]  J. Nicholson,et al.  Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. , 2003, Analytical biochemistry.

[3]  H. Adlercreutz,et al.  Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  K. Setchell,et al.  Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. , 2003, The Journal of nutrition.

[5]  J. Paul Robinson,et al.  Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production* , 2003, The Journal of Biological Chemistry.

[6]  T. Kojima,et al.  Hypolipidemic action of the soybean isoflavones genistein and genistin in glomerulonephritic rats , 2002, Lipids.

[7]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[8]  T Ranich,et al.  Protective effects of dietary phytoestrogens in chronic renal disease. , 2001, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[9]  E Holmes,et al.  Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. , 2001, Analytical biochemistry.

[10]  D. Leitman,et al.  Estrogen Receptor β-Selective Transcriptional Activity and Recruitment of Coregulators by Phytoestrogens* , 2001, The Journal of Biological Chemistry.

[11]  K. Setchell,et al.  Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. , 2001, The Journal of nutrition.

[12]  T. Claridge High-Resolution NMR Techniques in Organic Chemistry , 1999 .

[13]  H. Rehman Fish odour syndrome , 1999 .

[14]  K. Setchell,et al.  Dietary isoflavones: biological effects and relevance to human health. , 1999, The Journal of nutrition.

[15]  W. Mazur,et al.  Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). , 1998, The Journal of nutrition.

[16]  R. A. King,et al.  Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. , 1998, The American journal of clinical nutrition.

[17]  B. Katzenellenbogen,et al.  The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Setchell,et al.  Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products , 1995, British Journal of Nutrition.

[19]  David J. Livingstone,et al.  Data analysis for chemists , 1995 .

[20]  K. Setchell,et al.  Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. , 1994, The American journal of clinical nutrition.

[21]  G. D'Amico,et al.  Influence of diet on lipid abnormalities in human renal disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  H. Adlercreutz,et al.  Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. , 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[23]  R. Trevisan,et al.  Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. , 1990, Kidney international.

[24]  George H. Dunteman,et al.  Principal Components Analysis , 1990 .

[25]  S. Bingham,et al.  The use of 4-aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. , 1983, Clinical science.